Viemed Healthcare
VMD
104 hedge funds and large institutions have $184M invested in Viemed Healthcare in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 37 reducing their positions, and 20 closing their positions.
140% more call options, than puts
Call options by funds: $12K | Put options by funds: $5K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
16% more capital invested
Capital invested by funds: $159M → $184M (+$25.6M)
0.34% less ownership
Funds ownership: 61.31% → 60.97% (-0.34%)
7% less funds holding
Funds holding: 112 → 104 (-8)
16% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 37
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$2.45M |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
+$2.2M |
| 3 |
AIC
AWM Investment Company
New York
|
+$1.68M |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$1.35M |
| 5 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$1.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$2.31M |
| 2 |
TPM
Triasima Portfolio Management
Montreal,
Quebec, Canada
|
-$2.18M |
| 3 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$1.37M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$942K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$713K |
VMD Hedge Fund Activity: Q4 2023 in Review
104 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q4 2023, worth a combined $184M — up 16% from $159M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of VMD and 12 opened new positions — a net loss of 8 holders — while 37 trimmed existing stakes and 31 added.
The largest buyer was Morgan Stanley, adding an estimated $2.45M. The largest seller was Connor, Clark & Lunn Investment Management (CC&L), cutting an estimated $2.31M.
- 104 institutional investors held Viemed Healthcare (VMD) as of Q4 2023, down from 112 in Q3 2023.
- Funds reported $184M of Viemed Healthcare stock for Q4 2023, up 16% quarter-over-quarter.
- 12 funds opened new Viemed Healthcare positions in Q4 2023 and 20 closed out, a net change of -8 holders.
- The largest Viemed Healthcare buyer in Q4 2023 was Morgan Stanley, an estimated $2.45M added.
- The largest Viemed Healthcare seller in Q4 2023 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $2.31M sold.
Based on aggregated 13F filings for Q4 2023.